H1-receptor antagonists: Effects on leukocytes, myth or reality?

Clinical and Experimental Allergy, Supplement

Volumn 29, Issue 3, 1999, Pages 60-63

  De Vos, C ^a  

^a UCB PHARMA   (Belgium)

Author keywords

Allergy; Cetirizine; Leukocyte infiltration; Mast cell degranulation

Indexed keywords

ASTEMIZOLE; CETIRIZINE; CHLORPHENIRAMINE; CROMOGLYCATE DISODIUM; FEXOFENADINE; HISTAMINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; KETOTIFEN; LORATADINE; OXATOMIDE; TERFENADINE;

ALLERGIC REACTION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG ACTIVITY; DRUG EFFECT; EOSINOPHIL; HISTAMINE RELEASE; HUMAN; LEUKOCYTE; MAST CELL DEGRANULATION; MEDIATOR RELEASE; PRIORITY JOURNAL; ANIMAL; BASOPHIL; MAST CELL; REVIEW;

ANIMALS; BASOPHILS; HISTAMINE H1 ANTAGONISTS; HUMANS; LEUKOCYTES; MAST CELLS;

MLCS; MLOWN;

EID: 0032813426     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Kreutner W, Chapman RW, Gulbenkian A, Siegel MI. Anti-allergic activity of loratadine, a non-sedating antihistamine. Allergy 1997; 42:57-63.
2. 1-antagonist loratadine on histamine release from human basophils. Int Arch Allergy Immunol 1994; 105:12-17.
3. Delpon E, Valenzuela C, Gay P, Franqueza L, Snyders DJ, Tamargo J. Block of human cardiac Kv1.5 channels by loratadine: voltage-, time- and use-dependent block at concentration above therapeutic levels. Cardiovascular Research 1997; 35:341-350.
4. Haria M, Fitton A, Peters DH. Loratadine. A reappraisal of its pharmacological properties and therapeutic use in allergic disorders. Drugs 1994; 48:617-637.
5. 1-Receptor Antagonists in Allergic Disease, Chap. 5. New York: Dekker. 1996; 117-144.
6. Montefort S, Gratziou C, Goulding D, et al. Bronchial biopsy evidence of leukocyte infiltration and upregulation of leukocyte endothelial cell adhesion molecules, 6 hours after local allergen challenge of sensitized asthmatic airways. J Clin Invest 1994; 93:1411-21.
7. Sehmi R, Walsh GM, Hartnell A et al. Modulation of human eosinophil chemotaxis and adhesion by anti-allergic drugs in vitro. Pediatr Allergy Immunol 1993; 4 (Suppl. 4):13-18.
8. De Vos C, Joseph M, Leprevost C, et al. Inhibition of human eosinophil chemotaxis and of the IgE-dependent stimulantion of human blood platelets by cetirizine. Int Arch Allergy Appl Immunol 1989; 88:212-215.
9. Fadel R, Herpin-Richard N, Henocq E, Rihoux JP. Inhibitory effect of cetirizine, 2HCl on eosinophil migration in vivo. Clin Allergy 1987; 17:373-9.
10. Michel L, De Vos C, Rihoux JP, et al. Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin. J Allergy Clin Immunol 1988; 82:101-9.
11. Fadel R, Herpin-Richard N, Dufresne F, Rihoux JP. Pharmacological modulation by cetirizine and loratadine of antigen and histamine-induced skin weals and flares, and late accumulation of eosinophils. J Int Med Res 1990; 18:366-71.
12. Roquet A, Raud J, Halldén G, et al. Effects of loratadine on anti-IgE-induced inflammation, histamine release, and leukocyte recruitment in skin of atopies. Allergy 1995; 50: 414-20.
13. 1-receptor blockade on the early and late response to cutaneous allergen challenge. J Pharmacol Exp Ther 1992; 262:964-70.
14. Atkins PC, Zweiman B, Moskovitz A, von Allmen C, Ciliberti M. Cellular inflammatory responses and mediator release during early developing late-phase allergic cutaneous inflammatory responses: Effects of cetirizine. J Allergy Clin Immunol 1997; 99:806-11.
15. Varney V, Gaga M, Frew AJ, De Vos C, Kay AB. The effect of a single oral dose of prednisolone or cetirizine on inflammatory cells infiltrating allergen-induced cutaneous late-phase reactions in atopic subjects. Clin Exp Allergy 1992; 22:43-9.
16. Taborda-Barata L, Jacobson M, Walker S, et al. Effect of cetirizine and prednisolone on cellular infiltration and cytokine mRNA expression during allergen-induced late cutaneous responses. Clin Exp Allergy 1996; 26:68-78.
17. Zweiman B, Atkins PC, Moskowitz A, et al. Cellular inflammatory response during immediate, developing, and established late phase allergic cutaneous reactions: effects of cetirizine. J Allergy Clin Immunol 1997; 100:341-347.
18. Redier H, Chanez P, De Vos C, et al. Inhibitory effect of cetirizine on the bronchial eosinophil recruitment induced by inhalation challenge in patients with asthma. J Allergy Clin Immunol 1992; 90:215-224.
19. Ciprandi G, Buscaglia S, Pesce G, et al. Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early and late-phase reactions after allergen-specific challenge. J Allergy Clin Immunol 1995; 95:612-21.
20. Fasce L, Ciprandi G, Pronzato C, et al. Cetirizine reduces ICAM-1 on epithelial cells during nasal minimal persistent inflammation in asymptomatic children with mite-allergic asthma. Int Arch Allergy Immunol 1996; 109:272-6.
21. ETAC® Study Group. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomized, placebo-controlled trial: First results of ETAC®. Pediatr Allergy Immunol 1998; 9:116-24.